Very little data have been published on cytogenetic abnormalities in Hodgkin's disease (HD) and their correlation with clinicopathologic features are scanty. We have performed chromosomal analysis of lymph nodes from 60 previously untreated HD patients and obtained analyzable metaphases in 49 patients (82%). Chromosomal abnormalities were found in 33 patients (55%) but only 31 karyotypes could be, at least partially, described. Twenty-nine cases showed numerical abnormalities that involved all chromosomes with the exception of chromosomes 13 and Y, which were gained less frequently and lost more frequently than other chromosomes. Structural abnormalities were found in 30 cases, involving all chromosomes except Y. Chromosomal regions 12pll-13, 13pll-13, 3q26-28, 6q15-16, and 7q31-35 were rearranged in more than 20% of the analyzable cases. No correlation was found between cytogenetic findings and ODGKIN'S DISEASE (HD) is a neoplastic disorder H of unknown origin. Although chromosomal abnormalities have been reported for more than 25 years,' reports are few, and in a recent review of the literature, Thangavelu and LeBeau' could only find 40 well-documented cases of abnormal karyotypes, studied by banding techniques, in HD.
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ODGKIN'S DISEASE (HD) is a neoplastic disorder
H of unknown origin. Although chromosomal abnormalities have been reported for more than 25 years,' reports are few, and in a recent review of the literature, Thangavelu and LeBeau' could only find 40 well-documented cases of abnormal karyotypes, studied by banding techniques, in HD.
HD is characterized, histologically, by the presence of Reed-Sternberg cells or their variants associated with numerous reactive cells. 3 One of the difficulties in karotyping HD arises from the scarcity of neoplastic cells, which account for only a very small percentage of the total cells present in involved lymph nodes: However, it has been recently suggested, using the morphology-antibody-chromosome method, that clonal chromosomal abnormalities found in HD could be restricted to the Reed-Sternberg cells5
In this report we describe chromosomal analysis of lymph nodes from 60 patients with previously untreated HD. We have compared the cytogenetic findings with clinical and histologic features and with karyotype abnormalities found in non-Hodgkin's lymphomas (NHL).
(P < .02), and 2Oq12-13 (P < .05) were more frequent in HD.
When compared with T-cell lymphomas, only defects in regions 12~12-13 (P < .01) and 13pll-13 (P < .01) were more frequent in HD. Failure t o obtain analyzable metaphases was correlated with stage IV of the disease (P < .05) and with a poor survival (P < .Ol), but cytogenetic results showed no other correlation with clinical outcome. We conclude that molecular studies in HD should be focused on the short arms of chromosomes 12 and 13. Determination of the clinical significance of cytogenetic findings will require a larger number of patients and a longer follow-up period. 0 1991 b y The American Society of Hematology.
(P < .Ol), 13~11.13 (P < .01), 1 4~1 1 (P < .01), 15~11-13 Tissue samples. Fresh lymph nodes were divided into two portions for morphologic and cytogenetic studies. All histologic material was reviewed by the same pathologist (C.D.), without knowledge of cytogenetic data, and classified according to the Lukes-Rye scheme! The portion for cytogenetic studies was transported in RPMI medium containing 5% fetal calf serum (FCS) .
MATERIALS AND METHODS

Patient
Biopsy specimens were minced and cells were dissociated through a fine needle; 2 x lo6 cells were cultured at 3 7 T , pH 7.4, for 16 hours in RPMI medium supplemented with +12,+13,+13,+15,+16,+16,+16,+17,+18,+19,+20,+20,+21, +21 ,del(6)(ql5q24),del (7) (q21),t(9:?)(p21;?),t(lO:l8)(pl4:ql2),t(l3;l5)(pll;ql l),t(l4: 14)(pl l:ql2),del (14) ?),der( 8)t(8: 15)(pll:ql l),+der(8)t(8;15)(pll:ql l),t(9:9)(pl l;q31),+der(9)t(9:
9)(9qter -9q31::9pl1-9qter),+der(9)t(9:9)(9pter-+9q31: : 9~11-+9pter),+der(9)t(9;9) (9pter+9q31: :9pll+gpter),der ( 13) (4)(q27),dup(9)(q2l-+q34),+2mar  9O,X,-Y,+X,+1,+1,+2,+2,+3,+3,+4,+4,+5,+5,+5,+6,+7,+8,+8,+9,+9,-l1 For Initial characteristics, response to treatment, and cytogenetic findings were tabulated and compared with the x2 test (with Yates correction when appropriate) for discrete variables and by Mann and Whitney's U-test for continuous characteristics. Survival was calculated from the onset of treatment to death or to the date when the patient was last known to be alive. DFS was calculated from the date of remission to relapse or to the date the patient was last known to be free of disease. Overall survival and DFS duration analysis were based on the KaplanMeier estimate and compared with the log-rank test. Analyses were performed on a personal computer (software developed by P.
Kwiatkowski, Centre Jean Perrin, Clermont-Ferrand, France).
Statistical analysis.
RESULTS
Cytogenetic findings in the 60 patients are shown in Table 1 . Analyzable metaphases were obtained in 49 of the 60 patients (82%). Chromosomal abnormalities were found in 33 patients (55%), with only normal diploid metaphases being seen in the remaining cases. Thirty-two of these 33 patients had an admixture of normal and abnormal metaphases, with the percentage of abnormal metaphases ranging from 6% to 100% (median: 47%).
In three of these patients (patients 2,8, and 28) only one abnormal metaphase was found. Because the abnormalities were similar to those found in other patients, these three cases were included in the analysis. Two patients (patients 5 and 18, both of lymphocyte-depleted subtype) had complex clonal abnormalities with metaphases that were of too poor quality to be analyzed. Thus, 31 cases were finally suitable for analysis of numerical and structural abnormalities.
Twenty-nine cases showed numerical abnormalities. Chromosome numbers varied from 44 to 96, but the usual pattern was nearly triploid (median: 67), and only one patient was hypodiploid. As shown in Fig 1, all chromosomes were involved in the gains, but chromosomes 2,5,9, and 12 were most frequently in excess, whereas chromosomes 13 and Y were gained less frequently than other chromosomes. Chromosomes 13,21, and Y were the most frequently lost.
Thirty cases had structural abnormalities that were at least partially analyzable. All chromosomes, except Y, were affected by these abnormalities. Translocations were the most common type, but deletions, duplications, inversions, and isochromosomes were also found. Structural abnormalities involving each chromosome arm are shown in Fig 2 and chromosome regions involved in three or more cases are listed in Table 2 . The chromosome regions most frequently rearranged were 12pll-13 (32% of the analyzable cases), 13pll-13 (29%), 3q26-28 (23%), 6q15-16 (23%), and 7q31-35 (23%). Clonal variations were detected in four patients and consisted mostly of differences in numerical abnormalities.
The proportion of cases with analyzable metaphases was 23 of 28 (82%) in the nodular sclerosis subtype and 20 of 25 (80%) in the mixed cellularity subtype. The proportion of cases with abnormal metaphases was 17 of 23 (74%) in the nodular sclerosis subtype and 12 of 20 (60%) in the mixed cellularity subtype. No statistical correlation was found For personal use only. on October 3, 2017. by guest www.bloodjournal.org From between cytogenetic findings and initial characteristics tested (Table 3) .
A comparison of the frequency of structural abnormalities in HD and NHL is shown in Fig 3. Defects at bands 12pll-13, 13pll-13, 14~11, and 15pll-13 were more frequent in HD, whereas defects at band 14q32, the most frequently involved in NHL, were significantly less frequent. When diffuse B-cell lymphomas were compared (Fig   4) , abnormalities involving bands 2p25 (P < .Ol), 12pll (P < .02), and 2Oq12-13 (P < .05) were more frequently found in HD. When T-cell lymphomas were considered (Fig 5) , only defects at bands 12pll-13 (P < .01) and 13pll-13 (P < .01) appeared significantly more frequent in HD.
The median follow-up at the time of this analysis (February 1990) is 33 months. Six patients are dead: two were early deaths related to therapy (patients 5 and 35), two were failures of initial treatment (patients 15 and 23), and two were deaths after relapse (patients 1 and 4). Two patients have relapsed and are alive in second remission (patients 6 and 22). Fifty-two patients are alive in first remission. Stage was a prognostic factor for overall survival and DFS in this series (P < .02). As shown in Fig 6, failure to obtain analyzable metaphases was found to be of adverse prognostic significance (P < .01) and it was also correlated with stage IV of the disease (P < .OS), as three of the four patients with stage IV were in this case. Other cytogenetic findings did not appear to influence response to therapy, DFS. or overall survival. lq41, 2~2 5 , 3~1 1 , 7q31-35, 83322-23, 9~21-24, 11q21-23, (P < .Ol), 13~11-13 (P < .Ol), 1 4~1 1 (P < .Ol), 15~11-13 monly only a single abnormal mitosis can be found, and it is not clear whether a single metaphase of this sort can be interpreted as arising from the abnormal c10ne."~'~ Secondly, the complexity and poor quality of metaphases may preclude, as in two of our cases, a complete determination of the karyotype. In a recent review of the literature, Thangavelu and LeBeau' could find only 40 well-documented cases of the 11 published studies of HD karyotyped by banding techniques. Although it is known that karyotypes in HD are usually hyperdiploid with structural abnormalities, no pathognomonic chromosomal aberration or specific defect(s) have been consistently identified.
In the present series numerical abnormalities appeared to be nonrandom. Chromosome 13, as it has been previously noted,' was under-represented in chromosome gains and was one of the most frequently lost. This selective loss of chromosomal material suggests the possibility of loss of heterozygosity as a step in tumor de~elopment'~ as it has been seen in the retinoblastoma model, which also involves chromosome 13.15
Several structural abnormalities were found in at least 10% of the abnormal cases. Some of the chromosome regions found to be involved in HD are shared with NHL of either B-cell (eg, 14q32, 8q24, 6q, and 11q21-23)'62'7 or T-cell origin (eg, 4q28,I8 7q31-35," and 3q2717 ). Observations of this sort led Cabanillas et all9 to consider that HD might originate from a lymphoid cell. In our study, when comparing frequencies of involvement of chromosomal regions, significant differences were more numerous between HD and diffise B-cell NHL than between HD and T-cell NHL. This finding is in accordance with recent studies of immunophenotype20,21 and T-cell receptor p-chain expression" in HD, which suggested that at least some cases may arise from T cells.
Chromosome region 12pll-13 was involved in deletions or translocations in more than one third of the analyzable cases. A deletion at band 12pll has been described once in HD of mixed cellularity subtype.23 This region has also been implicated in some cases of childhood acute lymphoblastic le~kemia,'~ acute myeloblastic leukemia:' chronic myelomonocytic leukemia,'(' and in a case of large cell NHL. 16 The oncogene v-Ki-ras2 has been mapped to band 12~12:~ but its involvement in these diseases has not been demonstrated yet. It is worth noting that the deletion at band 1 2~1 2 was found as the sole abnormality in one of our patients (patient 53).
The frequency (29%) of involvement of band 13pll-13 is more surprising. In the 40 cases reviewed by Thangavelu and LeBeau: band 13pll-13 was involved on four occasions as it was in a Hodgkin-derived cell line described by Fonatsch et al.zs In these cases, as well as in six of our nine cases, the chromosomal abnormality consisted of a translocation of unidentified material. This defect emphasizes the possible role of chromosome 13 in the genesis of HD. However, the only known feature of this chromosome region is that it codes for ribosomal RNA."
Only one patient (patient 48) had a break at band 5q35, implicated in a deletion. In this patient, only small lymph node fragments with a typical aspect of HD could be obtained by mediastinoscopy, and further pattern assessment was not possible. Translocations involving this band have been found to be associated with CD30' anaplastic large cell lymphoma.M The absence of a similar translocation in HD could be of great interest to further define the gray area between HD and anaplastic large cell lymphoma.
Attempts to correlate cytogenetic findings with the histologic subtype of the disease are attractive. It has been suggested that the nodular sclerosis subtype provides more analyzable metaphases than does the mixed cellularity s~btype.'~ However, in our study both the proportion of analyzable metaphases and the proportion of abnormal metaphases was similar in both subtypes. No correlation between any chromosomal numerical or structural abnorFor personal use only. on October 3, 2017. by guest www.bloodjournal.org From malities and histologic subtype or other initial characteristics could be found in our study.
The prognostic significance of a failure to obtain analyzable metaphases in this study must be interpreted with extreme caution. However, study of survival did not support Schouten et al,13 who hypothesized that patients with an abnormal have a better Prognosis. In view of the heterogeneity of chromosomal changes, and the fact that most patients can now be cured, the recognition of putative cytogenetic prognostic factors in HD will certainly require a larger number of patients and a longer follow-up period.
